Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Classroom air cleaners could cut Kids' colds

NCT ID NCT05953233

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether portable HEPA air cleaners placed in elementary school classrooms can lower the amount of viruses in the air and reduce infections among students, teachers, and their families. About 200 participants from grades K-5 will be randomly assigned to classrooms with either working HEPA cleaners or sham cleaners that look the same but don't filter air. Researchers will track who gets sick and test for viruses in the air and in nose swabs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HEPA air cleaner
What this could lead to
If it works, this could show that simple air cleaners in schools help prevent respiratory infections in children and their families.
What could go wrong
This is a small, early-stage study in a few schools, so results may not apply everywhere. The sham cleaners may also reduce infections, making it hard to see a clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Aug 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 90 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Children * Grades K-5 (age 6-12 years) * Attend one of the schools that the study team has permission to obtain classroom/school environmental samples * Have no plans to move schools within the upcoming 12 months * Subject and/or parent guardian must be able to understand and provide informed consent and also willing to participate in the study Adults * Adult (age 21 or older) parent, caretaker, or household member of child participating in this study, or teacher in classroom participating in study * Able to understand and provide informed consent Exclusion Criteria: Children * Contraindication to or inability to participate in home self-collection of nasal swab samples * Severe chronic diseases (e.g. cancer, genetic or congenital disorders interfering with mobility) * Severe neurobehavioral, neurodevelopmental or psychiatric disorders requiring special assistance * Families who do not speak English or Spanish well enough to complete the survey questions, as validated versions in other languages are not available for all of the measures Adults * Contraindication to or inability to participate in home self-collection of nasal swab samples * Severe chronic diseases (e.g. cancer, genetic or congenital disorders interfering with mobility) * Severe neurobehavioral, neurodevelopmental or psychiatric disorders requiring special assistance * Families who do not speak English or Spanish well enough to complete the survey questions, as validated versions in other languages are not available for all of the measures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Viral infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mass General Brigham

    RECRUITING

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.